Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel

Emerging Infectious Diseases

Volumn 14, Issue 3, 2008, Pages 378-384

  Levy, Isaac ^a   Grisaru Soen, Galia ^a,j   Lerner Geva, Liat ^b   Kerem, Eitan ^c   Blau, Hana ^d   Bentur, Lea ^e   Aviram, Micha ^f   Rivlin, Joseph ^g   Picard, Elie ^h   Lavy, Anita ⁱ   Yahav, Yakov ^a   Rahav, Galia ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^e RAMBAM MEDICAL CENTER   (Israel)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g CARMEL MEDICAL CENTER   (Israel)

^h SHAARE ZEDEK MEDICAL CENTER   (Israel)

ⁱ Mycobacterium Reference Laboratory of Israel   (Israel)

^j TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASPERGILLUS; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH CENTER; HUMAN; ISRAEL; LUNG DISEASE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM SIMIAE; OBSERVATIONAL STUDY; PREVALENCE; RETROSPECTIVE STUDY; SPUTUM ANALYSIS;

EID: 41349117412     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1403.061405     Document Type: Article

References (34)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996;154:1229-56.
2. Olivier KN, Yankaskas JR, Knowles MR. Nontuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin Respir Infect. 1996;11:272-84.
3. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis. 1998;27:158-63.
4. Steinkamp G, Wiedemann B, Rietschel E, Krahl A, Gielen J, Bärmeier H, et al. The Emerging Bacteria Study Group. Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros. 2005;4:41-8.
5. Hjelte L, Petrini B, Kallenius G, Strandvik B. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax. 1990;45:397-400.
6. Kilby JM, Gilligan PH, Yankaskas JR, Highsmith WE Jr, Edwards LJ, Knowles MR. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest. 1992;102:70-5.
7. Aitken ML, Burke W, McDonald G, Wallis C, Ramsey B, Nolan C. Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest. 1993;103:1096-9.
8. Hjelt K, Hojlyng N, Howitz P, Illum N, Munk E, Valerius NH, et al. The role of mycobacteria other than tuberculosis (MOTT) in patients with cystic fibrosis. Scand J Infect Dis. 1994;26:569-76.
9. Tomashefski JF Jr, Stern RC, Demko CA, Doershuk CF. Nontuberculous mycobacteria in cystic fibrosis: an autopsy study. Am J Respir Crit Care Med. 1996;154:523-8.
10. Fauroux B, Delaisi B, Clement A, Saizou C, Moissenet D, Truffot-Pernot C, et al. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J. 1997;16:354-8.
11. Torrens JK, Dawkins P, Conway SP, Moya E. Non-tuberculous mycobacteria in cystic fibrosis. Thorax. 1998;53:182-5.
12. Bange FC, Kirschner P, Bottger EC. Recovery of mycobacteria from patients with cystic fibrosis. J Clin Microbiol. 1999;37:3761-3.
13. Oliver A, Maiz L, Canton R, Escobar H, Baquero F, Gomez-Mampaso E. Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis. 2001;32:1298-303.
14. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167:828-34.
15. Scientific Assembly on Microbiology, Tuberculosis and Pulmonary Infections, American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med. 1997;156:S1-25.
16. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416.
17. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, et al.; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med. 2003;167:835-40.
18. Metchock BG, Nolte FS, Wallace RJ Jr. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington: ASM Press; 1999. p. 399-437.
19. Zaher F, Marks J. Methods and medium for the culture of tubercle bacilli. Tubercle. 1977;58:143-5.
20. Collins CH, Grange JM, Yates MD. Tuberculosis bacteriology: organization and practice. 2nd ed. Oxford: Butterworth-Heinemann; 1997. p. 69-77.
21. Marks J. A system for the examination of tubercle bacilli and other mycobacteria. Tubercle. 1976;57:207-25.
22. Biehle JR, Cavalieri SJ, Saubolle MA, Getsinger LJ. Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria. J Clin Microbiol. 1995;33:1760-4.
23. Huminer D, Dux S, Samra Z, Kaufman L, Lavy A, Block CS, et al. Mycobacterium simiae infection in Israeli patients with AIDS. Clin Infect Dis. 1993;17:508-9.
24. Al-Abdely HM, Revankar SG, Graybill JR. Disseminated Mycobacterium simiae infection in patients with AIDS. J Infect. 2000;41:143-7.
25. Barzilai A, Rubinovich B, Blank-Porat D, Rubinstein E, Keller N, Levi I. Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients. Scand J Infect Dis. 1998;30:143-6.
26. Rose HD, Dorff GJ, Lauwasser M, Sheth NK. Pulmonary and disseminated Mycobacterium simiae infection in humans. Am Rev Respir Dis. 1982;126:1110-3.
27. Bell RC, Higuchi JH, Donovan WN, Krasnow I, Johanson WG Jr. Mycobacterium simiae. Clinical features and follow-up of twenty-four patients. Am Rev Respir Dis. 1983;127:35-8.
28. Conger NG, O'Connell RJ, Laurel VL, Olivier KN, Graviss EA, Williams-Bouyer N, et al. Mycobacterium simiae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol. 2004;25:1050-5.
29. Valero G, Peters J, Jorgensen JH, Graybill JR. Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review. Am J Respir Crit Care Med. 1995;152:1555-7.
30. Lavy A, Yoshpe-Purer Y. Isolation of Mycobacterium simiae from clinical specimens in Israel. Tubercle. 1982;63:279-85.
31. Samra Z, Kaufman L, Pitlik S, Shalit I, Bishara J. Emergence of Mycobacterium simiae in respiratory specimens. Scand J Infect Dis. 2005;37:838-41.
32. Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, et al.; Macrolide Study Group. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2003;290:1749-56.
33. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of highdose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995;332:848-54.
34. Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today. 1991;12:349-52.